.AstraZeneca has actually shared a very early check out the performance of its own internal antibody...
.After declaring a period 3 launch based on positive midstage outcomes, iTeos and GSK are eventually...
.The FDA ought to be actually much more open and collective to discharge a rise in approvals of unco...
.It's an unusually hectic Friday for biotech IPOs, with Zenas BioPharma, MBX and also Bicara Therape...
.Atea Pharmaceuticals' antiviral has actually fallen short yet another COVID-19 trial, yet the biote...
.Neurocrine Biosciences' schizophrenia plan pivot has actually neglected. The biotech was incapable ...
.Sanofi has actually brought in a late access to the radioligand event, paying 100 thousand euros ($...
.After F2G's initial try to acquire a new course of antifungal to market was actually hindered due t...
.Moderna has promised to cut R&D investing through $1.1 billion through 2027. The selection to re...
.Only four months after Sanofi bet $80 thousand in upfront cash on Fulcrum Therapies' losmapimod, th...